Oncolytics Biotech Inc.

TSX:ONC Rapporto sulle azioni

Cap. di mercato: CA$125.6m

Oncolytics Biotech Gestione

Gestione criteri di controllo 3/4

Oncolytics Biotech Il CEO è Wayne Pisano, nominato in Jun2024, ha un mandato di meno di un anno. possiede direttamente 0.25% delle azioni della società, per un valore di CA$ 309.60K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.9 anni e 5.5 anni.

Informazioni chiave

Wayne Pisano

Amministratore delegato

CA$165.0k

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEO0.2%
Durata media del management2.9yrs
Durata media del Consiglio di amministrazione5.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Feb 23
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Nov 10
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Jul 07
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Mar 24
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?

Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

Dec 09
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Aug 25
We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

May 12
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Dec 02
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Aug 05
We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth

Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

Apr 15
Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth

We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

Dec 31
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully

AMMINISTRATORE DELEGATO

Wayne Pisano (69 yo)

less than a year

Mandato

CA$165,010

Compensazione

Mr. Wayne F. Pisano, MBA, is Interim Chief Executive Officer at Oncolytics Biotech Inc. since June 24, 2024. He has been an Independent Director of Altimmune, Inc. since August 30, 2018. Mr. Pisano had bee...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Wayne Pisano
Interim CEO & Chairman of the Boardless than a yearCA$165.01k0.25%
CA$ 309.6k
Kirk Look
Chief Financial Officer12yrsCA$1.32m1.16%
CA$ 1.5m
Matthew Coffey
Presidentless than a yearCA$2.25m0.12%
CA$ 157.0k
Thomas Heineman
Chief Medical Officer2.9yrsCA$1.36m0.67%
CA$ 841.4k
Allison Hagerman
Vice President of Product Development6.1yrsCA$727.64k0.67%
CA$ 842.3k
Amy Levin
Vice President of Clinical Operations1.8yrsCA$683.55kNessun dato
Jon Patton
Director of Investor Relations & Communicationno dataNessun datoNessun dato
John Lievonen
Consultant5.5yrsCA$25.98kNessun dato

2.9yrs

Durata media

Gestione esperta: Il team dirigenziale di ONC è considerato esperto (durata media dell'incarico 2.9 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Wayne Pisano
Interim CEO & Chairman of the Board11.5yrsCA$165.01k0.25%
CA$ 309.6k
Bernd Seizinger
Independent Director9.4yrsCA$123.96k0.49%
CA$ 619.6k
James Parsons
Independent Director2.4yrsCA$116.36kNessun dato
Jonathan M. Rigby
Independent Director2.3yrsCA$107.40k0.41%
CA$ 513.2k
Patricia S. Andrews
Independent Directorless than a yearNessun datoNessun dato
Angela Holtham
Independent Director10.4yrsCA$130.58k0.17%
CA$ 207.4k
Jean-Pierre Bizzari
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Padmanee Sharma
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Dirk Arnold
Member of Scientific Advisory Boardless than a yearNessun datoNessun dato
Deborah Brown
Independent Director7yrsCA$124.95k0.064%
CA$ 79.8k
Martine Piccart
Member of Scientific Advisory Board7yrsNessun datoNessun dato
Richard Vile
Member of Scientific Advisory Board4.1yrsNessun datoNessun dato

5.5yrs

Durata media

68yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ONC sono considerati esperti (durata media dell'incarico 5.5 anni).